Total planned funding: $148,753,624
Allocations
Countries/Regions
Ukraine | $148,753,624 |
Organizational Types
Unknown | $39,275,090 |
NGO | $33,986,321 |
Private Contractor | $29,790,981 |
Own Agency | $18,964,931 |
Multi-lateral Agency | $11,425,607 |
University | $7,827,000 |
Implementing Agency | $4,172,000 |
Other USG Agency | $3,061,694 |
Host Country Government Agency | $250,000 |
Program Areas
Governance and Systems | $67,945,111 |
Treatment | $27,549,052 |
Testing | $16,911,209 |
Prevention | $13,432,088 |
Management and Operations | $13,280,660 |
Care | $9,222,804 |
Budget Codes
OHSS: Health Systems Strengthening | $38,431,681 |
HVSI: Strategic Information | $17,613,684 |
HVCT: Testing: HIV Testing and Counseling | $16,911,209 |
HTXS: Treatment: Adult Treatment | $15,117,938 |
HVMS: Management and Operations | $13,280,660 |
HTXD: Treatment: ARV Drugs | $12,431,114 |
HLAB: Laboratory Infrastructure | $11,899,746 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,357,044 |
HVTB: Care: TB/HIV | $5,676,355 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,404,893 |
HBHC: Care: Adult Care and Support | $2,398,305 |
HMBL: Biomedical Prevention: Blood Safety | $1,333,557 |
HKID: Care: Orphans and Vulnerable Children | $1,148,144 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $86,594 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $0 |
Top Partner Programs
Not Available:
$36,209,806
Countries/Regions
Chemonics International:
$16,719,470
Countries/Regions
USG Aggregated Agencies:
$14,213,195
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions